相关实验视频
Updated: Jan 15, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
903
肥胖和高血压管理中的新见解
Vince J Catalfamo1, Adrienne Koos1, Austin W Tutor2
1Department of Internal Medicine, Ochsner Health Foundation.
Current opinion in cardiology
|October 12, 2025
概括
肥胖相关的高血压正在上升,增加心血管疾病的风险. 新兴研究发现了新的机制和治疗方法,包括饮食干预和新疗法,以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 近几十年来,肥胖患病率增加了四倍,同时高血压率上升.
- 肥胖和高血压的综合负担显著增加了心血管疾病 (CVD) 的风险.
- 肥胖相关高血压的最佳管理策略正在不断发展.
研究的目的:
- 审查了解肥胖相关高血压病理生理学的最新进展.
- 探索新兴的治疗方案来管理这种情况.
- 突出这些进展在塑造未来实践中的临床相关性.
主要方法:
- 文献综述综合了最近的研究发现.
- 对已识别的病理生理机制进行分析.
- 评估新和传统的治疗干预措施.
主要成果:
- 关键的病理生理机制包括失调的荷尔蒙信号传递,增加的同情活动和炎症.
- 新的饮食干预措施显示出患者持续减肥的前景.
- 糖尿病药物和其他新型疗法与传统抗高血压药物一起显示出有效性.
结论:
- 精准医学方法正在推动针对肥胖相关高血压的向治疗策略.
- 新兴疗法有可能减少心血管疾病负担并改善患者的治疗结果.
- 进一步的研究对于完善治疗指南和优化干预措施至关重要.
相关概念视频
Hypertension V: Nursing Management
357
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
357
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Hypertension and Regulation of Blood Pressure
3.7K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.7K
Hypertension IV: Drug Therapy and Lifestyle Modifications
621
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
621
Diabetes: Management and Pharmacotherapy
867
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
867
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
246
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
246

